- Home
- JWN vs RNA Comparison
JWN vs RNA Comparison
Compare JWN & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JWN
- RNA
- Stock Information
- Founded
- JWN 1901
- RNA 2012
- Country
- JWN United States
- RNA United States
- Employees
- JWN N/A
- RNA N/A
- Industry
- JWN Clothing/Shoe/Accessory Stores
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- JWN Consumer Discretionary
- RNA Health Care
- Exchange
- JWN Nasdaq
- RNA Nasdaq
- Market Cap
- JWN 4.0B
- RNA 3.7B
- IPO Year
- JWN N/A
- RNA 2020
- Fundamental
- Price
- JWN $24.47
- RNA $31.60
- Analyst Decision
- JWN Hold
- RNA Strong Buy
- Analyst Count
- JWN 12
- RNA 12
- Target Price
- JWN $22.45
- RNA $68.25
- AVG Volume (30 Days)
- JWN 2.9M
- RNA 1.3M
- Earning Date
- JWN 03-04-2025
- RNA 05-08-2025
- Dividend Yield
- JWN 3.11%
- RNA N/A
- EPS Growth
- JWN 112.19
- RNA N/A
- EPS
- JWN 1.74
- RNA N/A
- Revenue
- JWN $15,016,000,000.00
- RNA $10,897,000.00
- Revenue This Year
- JWN $2.68
- RNA N/A
- Revenue Next Year
- JWN $1.45
- RNA $230.08
- P/E Ratio
- JWN $14.06
- RNA N/A
- Revenue Growth
- JWN 2.20
- RNA 13.98
- 52 Week Low
- JWN $17.20
- RNA $21.56
- 52 Week High
- JWN $24.99
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- JWN 65.35
- RNA 50.31
- Support Level
- JWN $24.17
- RNA $30.12
- Resistance Level
- JWN $24.49
- RNA $33.13
- Average True Range (ATR)
- JWN 0.08
- RNA 2.14
- MACD
- JWN 0.02
- RNA 0.14
- Stochastic Oscillator
- JWN 96.97
- RNA 35.92
Stock Price Comparison Chart: JWN vs RNA
About JWN Nordstrom Inc.
Nordstrom is a fashion retailer that operates about 93 department stores and 280 off-price Nordstrom Rack stores. The company also operates both full- and off-price e-commerce sites, two clearance stores, and six Local locations. Nordstrom's largest merchandise categories are women's apparel (27% of 2023 sales), shoes (26% of 2023 sales), men's apparel (15% of 2023 sales), and beauty (13% of 2023 sales). Nordstrom, which traces its history to a shoe store opened in Seattle in 1901, continues to be partially owned and managed by members of the eponymous family.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.